Robin Shane Readnour - Insider Trading & Ownership

Entity
Individual
Location
3835 Cleghorn Avenue, Suite 300, Nashville, TN
Summary
The estimated net worth of Robin Shane Readnour is at least $975K dollars as of December 10, 2024. Robin Shane Readnour is the Director of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $975K.
All Insider Reports
All Insider Reports

Ownership of Robin Shane Readnour

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ANTX AN2 Therapeutics, Inc. Director $975K +$294K +43.2% Dec 6, 2024

Insider Transactions Reported by Robin Shane Readnour:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.